Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer On Obamacare Rewind: No Short-Term Impact On Industry

Executive Summary

Pfizer CEO Ian Read explains why industry has stayed on the sidelines during the current health reform debate and defends drug pricing practices during a speech to the National Press Club.

Advertisement

Related Content

Pharma And Health Reform: Staying On The Sidelines Works Out
PhRMA And Trump: 'Go Boldly,' Or Tread Carefully?
Medicaid Block Grants: Allowing More State Flexibility To Limit Rx Coverage?
Pharma CEOs Tackle A Tough Question: “Why Don’t People Like You?”
Health Care Reform and the Biopharma Sector: A Complete Tactical Victory

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS120299

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel